Hypersomnia caused by isolated angiitis of the CNS

Internal Medicine

Volumn 44, Issue 8, 2005, Pages 883-885

  Nakaji, Kayoko ^a   Ikeda, Akio ^a   Oka, Yasunori ^a   Tomimoto, Hidekazu ^a   Shimohama, Shun ^a   Kanbayashi, Takashi ^b   Shibasaki, Hiroshi ^a,c  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TAKEDA GENERAL HOSPITAL   (Japan)

Author keywords

Hypersomnia; Isolated angiitis of the CNS; MLST; Orexin A

Indexed keywords

METHYLPREDNISOLONE; OREXIN A; PREDNISONE;

ADULT; ARTICLE; BRAIN BIOPSY; BRAIN BLOOD VESSEL; BRAIN VASCULITIS; CASE REPORT; CEREBROSPINAL FLUID LEVEL; CORTICOSTEROID THERAPY; DIAGNOSTIC IMAGING; DRUG PULSE THERAPY; FEMALE; HUMAN; HUMAN TISSUE; HYPERSOMNIA; HYPOTHALAMUS; LYMPHOCYTIC INFILTRATION; MEMORY DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYSOMNOGRAPHY; REM SLEEP; SLEEP PARAMETERS; SYMPTOMATOLOGY;

ADRENAL CORTEX HORMONES; ADULT; BIOPSY; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMORY DISORDERS; NEUROPEPTIDES; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 24644490849     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.883     Document Type: Article

References (14)

1. Cravioto H, Feigin I. Noninfectious granulomatous angiitis with a predilection for the nervous system. Neurology 9: 599-609, 1959.
2. Nishino S, Ripley B, Overeem S, et al. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 50: 381-388, 2001.
3. Alrawi A, Trobe JD, Blaivas M, Musch DC. Brain biopsy in primary angiitis of the central nervous system. Neurology 53: 858-860, 1999.
4. Cupps TR, Moore PM, Fauci AS. Isolated angiitis of the central nervous system: prospective diagnostic and therapeutic experience. Am J Med 74: 97-105, 1993.
5. Calabrese LH, Mallek JA. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine 67: 20-39, 1988.
6. Siva A. Vasculitis of the nervous system. J Neurol 248: 451-468, 2001.
7. Salin-Pascual R, Gerashchenko D, Greco M, Blanco-Centurion C, Shiromani PJ. Hypothalamic regulation of sleep. Neuropsychopharmacology 25: s21-27, 2001.
8. Mignot E, Taheri S, Nishino S. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat Neurosci 5: 1071-1075, 2002.
9. Nishino S. The hypocretin/orexin system in health and disease. Biol Psychiatry 54: 175, 2003.
10. Ebrahim IO, Semra YK, De Lacy S, et al. CSF hypocretin (Orexin) in neurological and psychiatric conditions. J Sleep Res 12: 83-84, 2003.
11. Iseki K, Mezaki T, Oka Y, et al. Hypersomnia in MS. Neurology 59: 2006-2007, 2002.
12. Kato T, Kanbayashi T, Yamamoto K, et al. Hypersomnia and low CSF hypocretin-1 (orexin A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions. Intern Med 42: 743-745, 2003.
13. Voderholzer U, Riemann D, Gann H, et al. Transient total sleep loss in cerebral Whipple's disease: a longitudinal study. J Sleep Res 11: 321-329, 2002.
14. Salomom RM, Ripley B, Kennedy JS, et al. Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol Psychiatry 54: 96-104, 2003.